AMTI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMTI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-06), Applied Molecular Transport's share price is $0.263. Applied Molecular Transport's Book Value per Share for the quarter that ended in Sep. 2023 was $0.40. Hence, Applied Molecular Transport's PB Ratio of today is 0.66.
The historical rank and industry rank for Applied Molecular Transport's PB Ratio or its related term are showing as below:
During the past 5 years, Applied Molecular Transport's highest PB Ratio was 17.31. The lowest was 0.00. And the median was 0.00.
During the past 12 months, Applied Molecular Transport's average Book Value Per Share Growth Rate was -80.30% per year.
The historical data trend for Applied Molecular Transport's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied Molecular Transport Annual Data | |||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | ||||||
PB Ratio | - | - | 8.21 | 3.30 | 0.27 |
Applied Molecular Transport Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
PB Ratio | Get a 7-Day Free Trial | 0.48 | 0.27 | 0.35 | 0.49 | 0.40 |
For the Biotechnology subindustry, Applied Molecular Transport's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Applied Molecular Transport's PB Ratio distribution charts can be found below:
* The bar in red indicates where Applied Molecular Transport's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Applied Molecular Transport's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Sep. 2023) |
= | 0.263 | / | 0.397 | |
= | 0.66 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Applied Molecular Transport (NAS:AMTI) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Applied Molecular Transport's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Shawn Cross | officer: Chief Financial Officer | 1825 K STREET SUITE 510, WASHINGTON DC 20006 |
Mahmood Tahir Ph.d. | director, officer: Chief Executive Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Brandon Hants | officer: VP, Finance & Bus. Ops. | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Douglas A. Rich | officer: Chief Technical Officer | C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362 |
Bittoo Kanwar | officer: Chief Medical Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Mrsny Randall Ph.d. | director, officer: Chief Scientific Officer | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
Aaron Vandevender | director | 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080 |
David Lamond | director | C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080 |
Epiq Capital Group, Llc | other: Managing member of 10% owner | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Chad Boeding | other: CEO of Managing Member | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Charlene A. Banard | director | C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080 |
John W Smither | director | C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301 |
Epq Llc Amt Ps | other: Owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Amtc Ps | other: Owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Amtb Ps | 10 percent owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
From GuruFocus
By Business Wire • 09-28-2023
By Business Wire • 09-21-2023
By Business Wire Business Wire • 07-10-2022
By Value_Insider Value_Insider • 11-10-2022
By PRNewswire • 10-04-2023
By PurpleRose PurpleRose • 07-12-2022
By Value_Insider Value_Insider • 11-07-2022
By PRNewswire • 10-10-2023
By PurpleRose PurpleRose • 07-15-2022
By PurpleRose PurpleRose • 08-10-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.